Association of Long-Term Atorvastatin with Escalated Stroke-Induced Neuroinflammation in Rats

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Molecular Neuroscience

• Publication date

  2016-08-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12031-016-0814-8PMID 27541018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Misinterpretation of trial evidence on statin adverse effects may harm patients

  2015cited by this paper
• Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms

  2014cited by this paper
• Essential role of axonal VGSC inactivation in time-dependent deceleration and unreliability of spike propagation at cerebellar Purkinje cells

  2014cited by this paper
• Long-term Effect of Telmisartan on Alzheimer’s Amyloid Genesis in SHR-SR After tMCAO

  2014cited by this paper
• Dose-Related Effects of Statins on Symptomatic Intracerebral Hemorrhage and Outcome After Thrombolysis for Ischemic Stroke

  2014cited by this paper
• Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: the potential molecular mechanisms.

  2014cited by this paper
• Ultra-Sensitive Molecular MRI of Vascular Cell Adhesion Molecule-1 Reveals a Dynamic Inflammatory Penumbra After Strokes

  2013cited by this paper
• Rho GTPase-dependent plasticity of dendritic spines in the adult brain

  2013cited by this paper
• Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials

  2013cited by this paper
• Mevalonate kinase deficiency, a metabolic autoinflammatory disease.

  2013cited by this paper
• The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials.

  2012cited by this paper
• Systematic Review and Meta-Analysis of the Efficacy of Statins in Experimental Stroke

  2012cited by this paper
• Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Evidence for the efficacy of statins in animal stroke models: a meta‐analysis

  2012cited by this paper
• Controversies in Stroke

  2012cited by this paper
• Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association

  2011cited by this paper
• Local, persistent activation of Rho GTPases during plasticity of single dendritic spines

  2011cited by this paper
• Prescription of lipophilic statins to Alzheimer’s disease patients: some controversies to consider

  2011cited by this paper
• Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study.

  2011cited by this paper
• Statins as Neuroprotectants: A Comparative In Vitro Study of Lipophilicity, Blood-Brain-Barrier Penetration, Lowering of Brain Cholesterol, and Decrease of Neuron Cell Death

  2011cited by this paper
• Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)

  2010cited by this paper
• Strategies for Study of Neuroprotection from Cold-preconditioning

  2010cited by this paper
• Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway.

  2010cited by this paper
• Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients

  2009cited by this paper
• The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.

  2008cited by this paper
• Effect of Pretreatment With Statins on Ischemic Stroke Outcomes

  2008cited by this paper
• Statins induce differentiation and cell death in neurons and astroglia

  2007cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

  2007cited by this paper
• Coenzyme Q10 and statins: biochemical and clinical implications.

  2007cited by this paper
• Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.

  2007cited by this paper
• Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages.

  2007cited by this paper
• Thematic review series: Lipid Posttranslational Modifications CAAX modification and membrane targeting of Ras Published, JLR Papers in Press, March 16, 2006.

  2006cited by this paper
• Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.

  2006cited by this paper
• Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke.

  2006cited by this paper
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

  2005cited by this paper
• Pleiotropic effects of statins: acutely good, but chronically bad?

  2005influential reference
• Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative Stress

  2005cited by this paper
• HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons.

  2005cited by this paper
• Protective Effects of Statins Involving Both eNOS and tPA in Focal Cerebral Ischemia

  2005cited by this paper
• Chronic Administration of Statins Alters Multiple Gene Expression Patterns in Mouse Cerebral Cortex

  2005cited by this paper
• Isoprenylated proteins

  2005cited by this paper
• Nonhuman primates are relevant models for research in hematology, immunology and virology.

  2005cited by this paper
• Role of Arginine Vasopressin V1 and V2 Receptors for Brain Damage After Transient Focal Cerebral Ischemia

  2005cited by this paper
• Reduction of Cerebral Infarction in Stroke-Prone Spontaneously Hypertensive Rats by Statins Associated With Amelioration of Oxidative Stress

  2005cited by this paper
• Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia*

  2004cited by this paper
• Pravastatin reduces microvascular basal lamina damage following focal cerebral ischemia and reperfusion.

  2004cited by this paper
• Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway.

  2004cited by this paper
• Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis

  2004cited by this paper
• P4-365 Brain availability and effects on lipid homeostasis of statins

  2004cited by this paper
• HMG‐CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis

  2004cited by this paper
• Severe irritability associated with statin cholesterol-lowering drugs.

  2004cited by this paper
• HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells

  2003cited by this paper
• The clinical use of HMG CoA‐reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications

  2003cited by this paper
• Blockade of HMG‐CoA reductase activity causes changes in microtubule‐stabilizing protein tau via suppression of geranylgeranylpyrophosphate formation: implications for Alzheimer's disease

  2003cited by this paper
• A road less travelled: large animal models in immunological research

  2003cited by this paper
• Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation

  2003cited by this paper
• Intensification of Free Radical Oxidation of Low-Density Lipoproteins in the Plasma of Patients with Ischemic Heart Disease Receiving beta-Hydroxy-beta-Methylglutaryl-Coenzyme A Reductase Inhibitor Cerivastatin and Inhibition of Low-Density Lipoprotein Peroxidation with Antioxidant Probucol

  2002cited by this paper
• Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors.

  2001cited by this paper
• Inhibitor of beta-hydroxy-beta-methylglutaryl coenzyme A reductase decreases energy supply to the myocardium in rats.

  2001cited by this paper
• Inhibitor of β-Hydroxy-β-Methylglutaryl Coenzyme A Reductase Decreases Energy Supply to the Myocardium in Rats

  2001cited by this paper
• Geranylgeranyl-Pyrophosphate, an Isoprenoid of Mevalonate Cascade, Is a Critical Compound for Rat Primary Cultured Cortical Neurons to Protect the Cell Death Induced by 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibition

  2000cited by this paper
• Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells.

  2000cited by this paper
• Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs.

  2000cited by this paper
• Fluvastatin and low-density lipoprotein oxidation in hypercholesterolemic renal transplant patients.

  1999cited by this paper
• [Are all HMG-CoA reductase inhibitors protective against ischemic heart disease?].

  1999cited by this paper
• Signaling molecules derived from the cholesterol biosynthetic pathway.

  1997cited by this paper
• A quantitative study of cerebrovascular variation in inbred mice.

  1990cited by this paper
• A Semiautomated Method for Measuring Brain Infarct Volume

  1990cited by this paper
• Malondialdehyde determination as index of lipid peroxidation.

  1990cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper
• Primary prevention of coronary heart disease.

  1985cited by this paper
• A modified spectrophotometric assay of superoxide dismutase.

  1984cited by this paper
• Catalase in vitro.

  1984cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• Statins as Neuroinflammatory Therapy, Bibliometric Study

  2024cites this paper
• Intra-arterial verapamil improves functional outcomes of thrombectomy in a preclinical model of extended hyperglycemic stroke

  2023cites this paper
• Compatibility of ingredients of Danshen (Radix Salviae Miltiorrhizae) and Honghua (Flos Carthami) and their protective effects on cerebral ischemia-reperfusion injury in rats

  2021cites this paper
• Atorvastatin modulates the expression of aging-related genes in the brain of aging induced by D-galactose in mice

  2021cites this paper
• FPS-ZM1 Alleviates Neuroinflammation in Focal Cerebral Ischemia Rats via Blocking Ligand/RAGE/DIAPH1 Pathway.

  2020cites this paper
• Regulation of Small GTPase Prenylation in the Nervous System

  2020cites this paper
• HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells

  2019cites this paper
• Coenzyme Q10 supplementation in acute ischemic stroke: Is it beneficial in short-term administration?

  2018cites this paper
• Coenzyme Q10 supplementation improves acute outcomes of stroke in rats pretreated with atorvastatin

  2017cites this paper
• Study of the influence and molecular mechanism of ticagrelor on cerebral ischemia reperfusion injury in rats

  2017cites this paper